Precigen, Inc. (PGEN) News
Filter PGEN News Items
PGEN News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
PGEN News Highlights
- PGEN's 30 day story count now stands at 2.
- Over the past 9 days, the trend for PGEN's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about PGEN are GENE.
Latest PGEN News From Around the Web
Below are the latest news stories about PRECIGEN INC that investors may wish to consider to help them evaluate PGEN as an investment opportunity.
Even after rising 15% this past week, Precigen (NASDAQ:PGEN) shareholders are still down 86% over the past three yearsPrecigen, Inc. ( NASDAQ:PGEN ) shareholders should be happy to see the share price up 16% in the last month. But the... |
Precigen to Present at the 42nd Annual J.P. Morgan Healthcare ConferencePrecigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced Helen Sabzevari, PhD, President and CEO of Precigen, will present a corporate and clinical overview at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024 at 5:15 PM PT/8:15 PM ET in San Francisco, California. |
5 ‘Jackpot’ Stocks to Buy for 2024 for 10X GainsThese stocks to buy have the potential to take your portfolio to the next level thanks to the cutting-edge technology they represent. |
Precigen to Participate in the JMP Securities Hematology and Oncology SummitPrecigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that Helen Sabzevari, PhD, President and CEO of Precigen, will participate in a fireside chat at the JMP Securities Hematology and Oncology Summit on Wednesday, December 6, 2023 at 3:00 PM ET. |
3 Penny Stocks to Buy to Turn $1 into $100: November 2023Are you looking for outsized gains for your portfolio. |
Precigen Reports Third Quarter 2023 Financial Results and Progress of Clinical ProgramsPrecigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced third quarter 2023 financial results and progress of clinical programs. |
Precigen to Participate in the Stifel 2023 Healthcare ConferencePrecigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced Helen Sabzevari, PhD, President and CEO of Precigen, will present a company overview at the Stifel 2023 Healthcare Conference on Wednesday, November 15, 2023 at 10:55 AM ET in New York. |
While institutions own 26% of Precigen, Inc. (NASDAQ:PGEN), private equity firms are its largest shareholders with 37% ownershipKey Insights Precigen's significant private equity firms ownership suggests that the key decisions are influenced by... |
Precigen to Participate in Upcoming Leading Investor and Industry ConferencesPrecigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced Helen Sabzevari, PhD, President and CEO of Precigen, will participate in the following upcoming investor and industry conferences: |
Fred Hassan Bought 185% More Shares In PrecigenPrecigen, Inc. ( NASDAQ:PGEN ) shareholders (or potential shareholders) will be happy to see that the Independent... |